A-84543 is a drug developed by Abbott, which acts as an agonist at neural nicotinic acetylcholine receptors with high selectivity for the α4β2 subtype. It is widely used in scientific research into the structure and function of this receptor subtype and has been the lead compound for the development of a large family of related derivatives.[1][2][3][4][5]
 | |
| Identifiers | |
|---|---|
| |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H16N2O |
| Molar mass | 192.257 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
References
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 8632405, please use {{cite journal}} with
|pmid=8632405instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 9871663, please use {{cite journal}} with
|pmid=9871663instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 9871663, please use {{cite journal}} with
|pmid=9871663instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 15771418, please use {{cite journal}} with
|pmid=15771418instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17371077, please use {{cite journal}} with
|pmid=17371077instead.
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |